|
Mass Spec Protein Assays in FFPE TissueWe are advancing personalized medicine with non-antibody protein assays that measure functional cancer signaling networks in FFPE tissue to individualize and improve patient treatment decisions.  Expression Pathology provides Roche SRM Protein Biomarker Assay Services Biomarker Summit 2012 ABRF 2012 Tissue Proteomic Workshop
Pharma Collaborations
Our broad menu of multiplexed Liquid Tissue®-SRM assays for major cancer signaling networks can advance development of targeted therapies and improve patient stratification needs. (More...) Clinical Applications
We are developing a CLIA certified facility to offer proprietary Liquid Tissue®-SRM molecular pathology tests that may improve evaluation of tumors and patient selection for targeted drugs, with EGFR and IGF-1R as the initial focus. (More...) Technology
Our patented Liquid Tissue®-SRM technology platform makes possible highly multiplexed quantitation by powerful mass spectrometry of minute amounts of laser microdissected FFPE tissue. (More...) |
custsvc@expressionpathology.com 